×
About 1,961 results

ALLMedicine™ Ebola Virus Center

Research & Reviews  953 results

Analysis of an Ebola virus disease survivor whose host and viral markers were predictiv...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798020
Genome Medicine; Bosworth A, Rickett NY et. al.

Jan 12th, 2021 - Ebola virus disease (EVD) is an often-fatal infection where the effectiveness of medical countermeasures is uncertain. During the West African outbreak (2013-2016), several patients were treated with different types of anti-viral therapies includi...

Identification Of Potential Inhibitors Of Protein-Protein Interaction Useful To Fight A...
https://doi.org/10.1016/j.antiviral.2021.105011
Antiviral Research; Lasala F, García-Rubia A et. al.

Jan 11th, 2021 - Despite the efforts to develop new treatments against Ebola virus (EBOV) there is currently no antiviral drug licensed to treat patients with Ebola virus disease (EVD). Therefore, there is still an urgent need to find new drugs to fight against EB...

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from ...
https://doi.org/10.1371/journal.pone.0245024
PloS One; Cai Y, Yu S et. al.

Jan 7th, 2021 - Ebola virus (EBOV), a member of the mononegaviral family Filoviridae, causes severe disease associated with high lethality in humans. Despite enormous progress in development of EBOV medical countermeasures, no anti-EBOV treatment has been approve...

Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspecti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765415
International Journal of Environmental Research and Public Health; Roychoudhury S, Das A et. al.

Dec 18th, 2020 - The twenty-first century has witnessed some of the deadliest viral pandemics with far-reaching consequences. These include the Human Immunodeficiency Virus (HIV) (1981), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) (2002), Influenza A ...

Regulation of VP30-Dependent Transcription by RNA Sequence and Structure in the Genomic...
https://doi.org/10.1128/JVI.02215-20
Journal of Virology; Bach S, Demper JC et. al.

Dec 3rd, 2020 - Viral transcription and replication of Ebola virus (EBOV) is balanced by transcription factor VP30, an RNA binding protein. An RNA hairpin at the transcription start site (TSS) of the first gene (NP hairpin) in the 3'-leader promoter is thought to...

see more →

Clinicaltrials.gov  983 results

Analysis of an Ebola virus disease survivor whose host and viral markers were predictiv...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798020
Genome Medicine; Bosworth A, Rickett NY et. al.

Jan 12th, 2021 - Ebola virus disease (EVD) is an often-fatal infection where the effectiveness of medical countermeasures is uncertain. During the West African outbreak (2013-2016), several patients were treated with different types of anti-viral therapies includi...

Identification Of Potential Inhibitors Of Protein-Protein Interaction Useful To Fight A...
https://doi.org/10.1016/j.antiviral.2021.105011
Antiviral Research; Lasala F, García-Rubia A et. al.

Jan 11th, 2021 - Despite the efforts to develop new treatments against Ebola virus (EBOV) there is currently no antiviral drug licensed to treat patients with Ebola virus disease (EVD). Therefore, there is still an urgent need to find new drugs to fight against EB...

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from ...
https://doi.org/10.1371/journal.pone.0245024
PloS One; Cai Y, Yu S et. al.

Jan 7th, 2021 - Ebola virus (EBOV), a member of the mononegaviral family Filoviridae, causes severe disease associated with high lethality in humans. Despite enormous progress in development of EBOV medical countermeasures, no anti-EBOV treatment has been approve...

Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspecti...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765415
International Journal of Environmental Research and Public Health; Roychoudhury S, Das A et. al.

Dec 18th, 2020 - The twenty-first century has witnessed some of the deadliest viral pandemics with far-reaching consequences. These include the Human Immunodeficiency Virus (HIV) (1981), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) (2002), Influenza A ...

Regulation of VP30-Dependent Transcription by RNA Sequence and Structure in the Genomic...
https://doi.org/10.1128/JVI.02215-20
Journal of Virology; Bach S, Demper JC et. al.

Dec 3rd, 2020 - Viral transcription and replication of Ebola virus (EBOV) is balanced by transcription factor VP30, an RNA binding protein. An RNA hairpin at the transcription start site (TSS) of the first gene (NP hairpin) in the 3'-leader promoter is thought to...

see more →

News  25 results

CDC Panel Recommends Ebola Vaccine for Adults With Exposure Risk
https://www.medscape.com/viewarticle/925810

Feb 26th, 2020 - The Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) unanimously recommended preexposure vaccination with the first-ever US Food and Drug Administration (FDA)–approved vaccine against Ebola v...

FDA OKs First Vaccine Against Deadly Ebola Virus
https://www.staging.medscape.com/viewarticle/922973

Dec 19th, 2019 - The US Food and Drug Administration (FDA) has approved the first vaccine for the prevention of Ebola caused by the deadly Zaire strain of the virus, which killed more than 11,000 people during the 2014 West Africa outbreak and is behind more than ...

FDA OKs First Vaccine Against Deadly Ebola Virus
https://www.medscape.com/viewarticle/922973

Dec 19th, 2019 - The US Food and Drug Administration (FDA) has approved the first vaccine for the prevention of Ebola caused by the deadly Zaire strain of the virus, which killed more than 11,000 people during the 2014 West Africa outbreak and is behind more than ...

'Trojan Horse' Might Take Ebola by Surprise
https://www.medpagetoday.com/infectiousdisease/ebola/60105

Sep 8th, 2016 - A new approach to antibody-based therapies might one day allow clinicians to target all strains of Ebola with a broad-spectrum drug. In early research, the "Trojan horse" antibodies were effective in preventing all five varieties of Ebola from inf...

Ebola Sexual Transmission 6 Months After Illness Confirmed
https://www.medscape.com/viewarticle/852693

Oct 13th, 2015 - Two Ebola virus (EBOV) studies published online today in the New England Journal of Medicine translate to one piece of advice: Men who have survived Ebola virus disease (EVD) should use condoms and treat semen as a potential source of infection, a...

see more →